Ophthalmology

Prof. Dr. Nursal Melda Yenerel

Doctor and researcher MEDİPOL Acıbadem Bölge Hastanesi İstanbul
Macular EdemaDiabetic RetinopathyKeratoconusMacular DegenerationExfoliation SyndromeMyopiaDiabetes MellitusCorneal EdemaAstigmatism

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Macular Edema 13 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Diabetic Retinopathy 12 publications
  • Keratoconus 6 publications
  • Macular Degeneration 6 publications
  • Exfoliation Syndrome 3 publications
  • Myopia 3 publications
  • Diabetes Mellitus 2 publications
  • Corneal Edema 2 publications
  • Astigmatism 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medipol.com.tr.

  • Retina Hastalıkları ve Tedavisi
  • Diyabetik Retinopati
  • Yaşa Bağlı Makula Dejenerasyonu
  • Retina Damar Tıkanıklıkları
  • Kalıtsal Retina Hastalıkları
  • Göz İçi Enjeksiyonlar
  • Katarakt Cerrahisi
  • Argon Lazer
  • Yag Lazer

CV

Education and experience

From source

Experience

  • 2018 - 2024Sağlık Bilimleri Üniversitesi Haydarpaşa SUAMmedipol.com.tr
  • 2012 - 2018Haydarpaşa Numune Eğitim ve Araştırma Hastanesimedipol.com.tr
  • 2001İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesimedipol.com.tr
  • 2003University of Washington School of Medicinemedipol.com.tr
  • 2005Dünya Göz Hastanesimedipol.com.tr
  • 2006Çevre Hastanesimedipol.com.tr
  • 2012Yeditepe Üniversitesi Tıp Fakültesimedipol.com.tr

Education

  • 2001İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Göz Hastalıkları ABDmedipol.com.tr
  • 1996Marmara Üniversitesi, Tıp Fakültesimedipol.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyOphthalmologymedipol.com.trFrom source
  • InstitutionMEDİPOL Acıbadem Bölge Hastanesimedipol.com.trFrom source
  • Area of workMacular EdemaExtracted from 13 publications · Model version —From source
  • Publications133 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 20:16https://medipol.com.tr/doktorlarimiz/profdr-nursal-melda-yenerelmedipol.com.tr

Scientific work

Publications on Macular Edema

133 publications
Publications by year Most: 16, in 2022
  1. 2005: 1 publication
  2. 2006: 0 publications
  3. 2007: 0 publications
  4. 2008: 9 publications
  5. 2009: 8 publications
  6. 2010: 8 publications
  7. 2011: 7 publications
  8. 2012: 4 publications
  9. 2013: 0 publications
  10. 2014: 0 publications
  11. 2015: 6 publications
  12. 2016: 7 publications
  13. 2017: 1 publication
  14. 2018: 2 publications
  15. 2019: 2 publications
  16. 2020: 4 publications
  17. 2021: 6 publications
  18. 2022: 16 publications
  19. 2023: 1 publication
  20. 2024: 4 publications
  21. 2025: 3 publications
  22. 2026: 3 publications
  1. Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study

    Ophthalmology and Therapy, 2026

    DOI 10.1007/s40123-026-01338-9 PMID 41739393 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Intravitreal Faricimab for Retinal Vein Occlusion: Real-World Outcomes from the Multicenter FARTURK-RVO Study in Türkiye

    Ophthalmology and Therapy, 2026

    DOI 10.1007/s40123-026-01436-8 PMID 42332211 Open-access full textSource: OpenAlex

  3. Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema

    European Journal of Ophthalmology, 2026

    DOI 10.1177/11206721261480211 PMID 42630057 Open-access full textSource: OpenAlex

  4. Wound morphologies of sclerotomies closed with scleral massage and scleral needling techniques: A comparative study

    Indian Journal of Ophthalmology, 2025

    DOI 10.4103/ijo.ijo_2184_24 PMID 40243079 Open-access full textSource: OpenAlex

  5. Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5

    Eye, 2025

    DOI 10.1038/s41433-025-03928-6 PMID 40664760 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  6. Evaluating the Effect of Nephropathy and Neuropathy on Response to Short-Term Intravitreal Anti-Vegf Treatment in Diabetic Macular Edema: An Optical Coherence Tomography-Angiography Study

    Current Eye Research, 2025

    DOI 10.1080/02713683.2025.2533345 PMID 40703022 Source: OpenAlex

  7. Real-life experience with ranibizumab and aflibercept in the treatment of neovascular age-related macular degeneration in turkey

    Journal of Retina-Vitreous, 2024

    DOI 10.37845/ret.vit.2024.33.6 Source: OpenAlex

  8. Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group

    European Journal of Ophthalmology, 2024

    DOI 10.1177/11206721241280737 PMID 39234628 Source: OpenAlex

  9. One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13

    Seminars in Ophthalmology, 2024

    DOI 10.1080/08820538.2024.2324450 PMID 39087722 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  10. Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10

    International Ophthalmology, 2024

    DOI 10.1007/s10792-024-03251-1 PMID 39317810 Source: OpenAlex

View all 133 publications